Back to Browse Journals » Neurobehavioral HIV Medicine » Volume 3

Stress management interventions for HIV-infected individuals: review of recent intervention approaches and directions for future research

Authors Brown JL, Vanable PA

Published Date November 2011 Volume 2011:3 Pages 95—106

DOI http://dx.doi.org/10.2147/NBHIV.S17829

Published 8 November 2011

Jennifer L Brown1,2, Peter A Vanable3
1Department of Behavioral Sciences and Health Education, 2Center for AIDS Research, Emory University, Atlanta, GA, USA; 3Department of Psychology, Syracuse University, Syracuse, NY, USA

Abstract: To promote psychological wellbeing and adaptive coping among people living with human immunodeficiency virus/acquired immune deficiency syndrome (PLWHA), a number of stress management interventions have been designed and evaluated. This paper reviews recent stress management intervention approaches designed to improve the coping skills of PLWHA and reduce psychological distress. First, a summary of findings from previous narrative reviews and meta-analyses of the stress management intervention literature for PLWHA is provided. Next, recent stress management interventions for PLWHA that fall into one of four categories are reviewed: (a) interventions to improve coping and modify other health behaviors (ie, highly active antiretroviral medication adherence, sexual behaviors), (b) meditation, mindfulness, and relaxation-based stress management approaches, (c) computer-delivered interventions, and (d) interventions that target specific populations including older individuals, individuals with childhood sexual abuse histories, and women. A critique of recent stress management interventions for PLWHA is provided as well as directions for future research.

Keywords: stress management intervention, stress, coping, cognitive behavioral stress management, review, HIV, HIV-positive, HIV-infected, AIDS

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Apolipoprotein-E genotype and human immunodeficiency virus-associated neurocognitive disorder: the modulating effects of older age and disease severity

Panos SE, Hinkin CH, Singer EJ, Thames AD, Patel SM, Sinsheimer JS, Del Re AC, Gelman BB, Morgello S, Moore DJ, Levine AJ

Neurobehavioral HIV Medicine 2013, 5:11-22

Published Date: 19 June 2013

The neuro-ophthalmology of HIV-AIDS review of Neurobehavioral HIV Medicine

Sudhakar P, Kedar S, Berger JR

Neurobehavioral HIV Medicine 2012, 4:99-111

Published Date: 18 September 2012

Immune activation and neuropsychiatric symptoms in human immunodeficiency virus type 1 infection

Schroecksnadel S, Kurz K, Weiss G, Fuchs D

Neurobehavioral HIV Medicine 2012, 4:1-13

Published Date: 16 January 2012

A guide to interpretation of neuroimmunological biomarkers in the combined antiretroviral therapy-era of HIV central nervous system disease

Katrina A Morris, Nicholas WS Davies, Bruce J Brew

Neurobehavioral HIV Medicine 2010, 2:59-72

Published Date: 24 August 2010

Rates of mood and anxiety disorders and contributors to continued heroin use in methadone maintenance patients: A comparison by HIV status

Allison J Applebaum, Jacqueline R Bullis, Lara N Traeger, et al

Neurobehavioral HIV Medicine 2010, 2:49-57

Published Date: 11 August 2010